CD274 and neoplasm: Moreover, not all patients with high PD-L1-expressing tumours (on IHC) showed benefits from checkpoint inhibition therapy, while conversely, patients with negative PD-L1 expression showed response to anti PD-L1 treatment in several cases [16,17].